Tourmaline Bio, Inc. (TRML)
Oct 28, 2025 - TRML was delisted (reason: acquired by NVS)
47.98
0.00 (0.00%)
Inactive · Last trade price on Oct 27, 2025
Tourmaline Bio Analyst Ratings
Total Analysts
12
Consensus Rating
Hold
Price Target
$49.05
Upside
+2.23%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Suspends n/a | Buy | Suspends | n/a | n/a | Oct 29, 2025 |
| BMO Capital | BMO Capital | Buy → Hold Downgrades $35 → $48 | Buy → Hold | Downgrades | $35 → $48 | +0.04% | Sep 15, 2025 |
| Piper Sandler | Piper Sandler | Buy → Hold Downgrades $65 → $48 | Buy → Hold | Downgrades | $65 → $48 | +0.04% | Sep 11, 2025 |
| Truist Securities | Truist Securities | Strong Buy → Hold Downgrades $63 → $48 | Strong Buy → Hold | Downgrades | $63 → $48 | +0.04% | Sep 10, 2025 |
| Guggenheim | Guggenheim | Strong Buy → Hold Downgrades $55 → $48 | Strong Buy → Hold | Downgrades | $55 → $48 | +0.04% | Sep 10, 2025 |
| Chardan Capital | Chardan Capital | Strong Buy → Hold Downgrades $70 → $48 | Strong Buy → Hold | Downgrades | $70 → $48 | +0.04% | Sep 10, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy → Hold Downgrades $50 → $48 | Strong Buy → Hold | Downgrades | $50 → $48 | +0.04% | Sep 10, 2025 |
| LifeSci Capital | LifeSci Capital | Buy → Hold Downgrades $48 | Buy → Hold | Downgrades | $48 | +0.04% | Sep 9, 2025 |
| Jefferies | Jefferies | Strong Buy → Hold Downgrades $64 → $48 | Strong Buy → Hold | Downgrades | $64 → $48 | -1.00% | Sep 9, 2025 |
| Wedbush | Wedbush | Buy → Hold Downgrades $48 | Buy → Hold | Downgrades | $48 | +0.04% | Sep 9, 2025 |
| Chardan Capital | Chardan Capital | Strong Buy Maintains $70 | Strong Buy | Maintains | $70 | +45.89% | Aug 14, 2025 |
| Guggenheim | Guggenheim | Strong Buy Reiterates $55 | Strong Buy | Reiterates | $55 | +14.63% | Aug 14, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $50 | Strong Buy | Reiterates | $50 | +4.21% | May 5, 2025 |
| Chardan Capital | Chardan Capital | Strong Buy Maintains $70 | Strong Buy | Maintains | $70 | +45.89% | May 5, 2025 |
| Chardan Capital | Chardan Capital | Strong Buy Initiates $70 | Strong Buy | Initiates | $70 | +45.89% | Apr 23, 2025 |
| Wedbush | Wedbush | Buy Maintains $42 → $43 | Buy | Maintains | $42 → $43 | -10.38% | Mar 14, 2025 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.